Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Non-Current Assets (2020 - 2025)

Agilon Health's Non-Current Assets history spans 6 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 112.94% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $4.0 million, up 112.94%, while the annual FY2025 figure was $4.0 million, 112.94% up from the prior year.
  • Non-Current Assets reached $4.0 million in Q4 2025 per AGL's latest filing, up from $1.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $293.8 million in Q1 2023 to a low of $130000.0 in Q2 2023.
  • Average Non-Current Assets over 5 years is $97.4 million, with a median of $3.3 million recorded in 2024.
  • Peak YoY movement for Non-Current Assets: tumbled 99.95% in 2023, then soared 2470.77% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $219.1 million in 2021, then increased by 7.81% to $236.2 million in 2022, then tumbled by 98.59% to $3.3 million in 2023, then crashed by 43.31% to $1.9 million in 2024, then skyrocketed by 112.94% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Non-Current Assets are $4.0 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).